This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global cell-based assays market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the cell-based assays market. The secondary sources used for this study include American Society for Cell Biology (ASCB), Federal Ministry of Education and Research (BMBF), Center for Commercialization of Regenerative Medicine (CCRM), Centers for Disease Control and Prevention (CDC), European Federation of Pharmaceutical Industries and Associations (EFPIA), International Agency for Research on Cancer (IARC), International Society for Advancement of Cytometry (ISAC), International Society for Stem Cell Research (ISSCR), National Center for Biotechnology Information (NCBI), National Institutes of Health (NIH), World Cancer Research Fund International (WCRF), World Health Organization (WHO), and Eurostat, Statista; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global cell-based assays market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical & biotechnology companies, contract research oragnizations (CROs), and academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across five major regions, including the Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Approximately 60% and 40% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the cell-based assays market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Bottom-up Approach and Top-down Approach
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.
To know about the assumptions considered for the study, Request for Free Sample Report
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Cell-based assays involve the use of cells to examine and assess different biochemical or cellular processes. These assays allow researchers to investigate the responses of cells under specific experimental conditions as well as to determine the effect of drugs on a particular cell line. These assays are also used to determine the potency of a drug by comparing the biological response related to its mode of action with that of a control preparation. Additionally, cell-based assays can be used in both biomedical research and drug-discovery screening applications for the quantification of cytotoxicity, biological activity, biochemical mechanisms and off-target interactions.
Stakeholders
-
Cell-based assay, consumable, instrument, and software manufacturers
-
Cell-based assay service providers
-
Cell-based assay vendors and distributors
-
Third-party suppliers, direct suppliers, distributors, and channel partners
-
Venture capitalists
-
Research & development (R&D) companies
-
Pharmaceutical & biotechnology companies
-
Research laboratories & academic institutes
-
Clinical research organizations (CROs)
-
Market research & consulting firms
-
Government & independent regulatory authorities
Report Objectives
-
To define, describe, and forecast the global cell-based assays market based on offering, technology, application, end user, and region
-
To provide detailed information on the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
-
To strategically analyze micromarkets in terms of individual growth trends, future prospects, and contributions to the overall cell-based assays market
-
To analyze opportunities in the global market for major stakeholders and provide a detailed competitive landscape for market leaders
-
To forecast the size of the market segments with respect to six major regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
-
To provide volume data for instruments used in cell-based assays
-
To strategically profile the key players in the global cell-based assays market and comprehensively analyze their core competencies2 and market rankings
-
To track and analyze competitive developments in the cell-based assays market, such as product launches, acquisitions, collaborations, expansions, and partnerships
-
To benchmark players within the cell-based assays market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business and product strategy
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment
-
Product Matrix, which gives a detailed comparison of the product portfolios of the top five companies.
Company Information
-
Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
-
A further breakdown of the Rest of Europe cell-based assays market into countries
-
A further breakdown of the Rest of Asia Pacific cell-based assays market into countries
-
A further breakdown of the Rest of Latin American cell-based assays market into countries
-
A further breakdown of the Rest of Middle East cell-based assays market into countries
Growth opportunities and latent adjacency in Cell Based Assays Market